BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lu C, Baraty B, Lee Robertson H, Filyk A, Shen H, Fung T, Novak K, Ma C, Panaccione R, Achkar JP, El Ouali S, Bruining D, Jairath V, Feagan B, Rieder F; Stenosis Therapy and Research (STAR) Consortium. Systematic review: medical therapy for fibrostenosing Crohn's disease. Aliment Pharmacol Ther. 2020;51:1233-1246. [PMID: 32406116 DOI: 10.1111/apt.15750] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Yao H, Tang G. Macrophages in intestinal fibrosis and regression. Cellular Immunology 2022. [DOI: 10.1016/j.cellimm.2022.104614] [Reference Citation Analysis]
2 Kante B, Vuyyuru SK, Kedia S, Sahu P, Kumar P, Ranjan MK, Virmani S, Sharma R, Madhusudhan KS, Panwar R, Das P, Makharia G, Ahuja V. Monotherapy with thiopurines in stricturing Crohn's disease: A real-life experience from low- and middle-income countries. Indian J Gastroenterol 2022. [PMID: 35997952 DOI: 10.1007/s12664-022-01258-z] [Reference Citation Analysis]
3 Duan M, Guan B, Cao L, Zhou C, Huang W, Wu Q, Zhu W, Li Y. Computed tomography enterography predicts surgical-free survival in symptomatic stricturing Crohn's disease. Abdom Radiol (NY) 2022. [PMID: 35896683 DOI: 10.1007/s00261-022-03588-0] [Reference Citation Analysis]
4 Hu K, He H, Yuan X, Du X, Liu R, Yang P, Yang Q, Zhang Y, Qiao J. Carboxymethyl Chitosan Oligosaccharide Holds Promise for Treatment of Stenosis Crohn’s Disease. ACS Pharmacol Transl Sci . [DOI: 10.1021/acsptsci.2c00035] [Reference Citation Analysis]
5 Santacroce G, Lenti MV, Di Sabatino A. Therapeutic Targeting of Intestinal Fibrosis in Crohn's Disease. Cells 2022;11:429. [PMID: 35159238 DOI: 10.3390/cells11030429] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
6 D'Alessio S, Ungaro F, Noviello D, Lovisa S, Peyrin-Biroulet L, Danese S. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34876680 DOI: 10.1038/s41575-021-00543-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
7 Singh S, Murad MH, Fumery M, Sedano R, Jairath V, Panaccione R, Sandborn WJ, Ma C. Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis. Lancet Gastroenterol Hepatol 2021;6:1002-14. [PMID: 34688373 DOI: 10.1016/S2468-1253(21)00312-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
8 Vieujean S, Loly JP, Boutaffala L, Meunier P, Reenaers C, Briquet A, Lechanteur C, Baudoux E, Beguin Y, Louis E. Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. J Crohns Colitis 2021:jjab154. [PMID: 34473270 DOI: 10.1093/ecco-jcc/jjab154] [Reference Citation Analysis]
9 Ueno A, Jijon HB, Peng R, Sparksman S, Mainoli B, Filyk A, Li Y, Wilson S, Novak K, Panaccione R, Hirota S, Dufour A, Lu C, Beck PL. Association of Circulating Fibrocytes With Fibrostenotic Small Bowel Crohn's Disease. Inflamm Bowel Dis 2021:izab157. [PMID: 34428284 DOI: 10.1093/ibd/izab157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Liu Q, Zhang X, Ko HM, Stocker D, Ellman J, Chen J, Hao Y, Bhardwaj S, Liang Y, Cho J, Colombel JF, Taouli B, Harpaz N. Constrictive and Hypertrophic Strictures in Ileal Crohn's Disease. Clin Gastroenterol Hepatol 2021:S1542-3565(21)00868-5. [PMID: 34400338 DOI: 10.1016/j.cgh.2021.08.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
11 Lee B, Lee JY, Kim J, Shin N, Yoo JM, Kang I, Kim J, Lee S, Kim D, Choi SW, Hong BH, Kang K. Oral administration of microbiome-friendly graphene quantum dots as therapy for colitis. 2D Mater 2021;8:025036. [DOI: 10.1088/2053-1583/abe362] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Sleiman J, El Ouali S, Qazi T, Cohen B, Steele SR, Baker ME, Rieder F. Prevention and Treatment of Stricturing Crohn's Disease - Perspectives and Challenges. Expert Rev Gastroenterol Hepatol 2021;15:401-11. [PMID: 33225766 DOI: 10.1080/17474124.2021.1854732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
13 Collyer R, Clancy A, Agrawal G, Borody TJ. Crohn’s strictures open with anti-mycobacterial antibiotic therapy: A retrospective review. World J Gastrointest Endosc 2020; 12(12): 542-554 [PMID: 33362907 DOI: 10.4253/wjge.v12.i12.542] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]